Glial fibrillary acidic protein as a biomarker in neuromyelitis optica spectrum disorder: a current review.
Patrick SchindlerOrhan AktasMarius RingelsteinBrigitte WildemannSven JariusFriedemann PaulKlemens RuprechtPublished in: Expert review of clinical immunology (2022)
NMOSD and could have the potential for application in clinical practice.